These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 11457994

  • 1. Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism.
    Thullier P, Demangel C, Bedouelle H, Mégret F, Jouan A, Deubel V, Mazié JC, Lafaye P.
    J Gen Virol; 2001 Aug; 82(Pt 8):1885-1892. PubMed ID: 11457994
    [Abstract] [Full Text] [Related]

  • 2. Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display.
    Frei JC, Kielian M, Lai JR.
    Virology; 2015 Nov; 485():371-82. PubMed ID: 26339794
    [Abstract] [Full Text] [Related]

  • 3. Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.
    Frei JC, Wirchnianski AS, Govero J, Vergnolle O, Dowd KA, Pierson TC, Kielian M, Girvin ME, Diamond MS, Lai JR.
    J Virol; 2018 Sep 15; 92(18):. PubMed ID: 29976679
    [Abstract] [Full Text] [Related]

  • 4. A recombinant Fab neutralizes dengue virus in vitro.
    Thullier P, Lafaye P, Mégret F, Deubel V, Jouan A, Mazié JC.
    J Biotechnol; 1999 Apr 15; 69(2-3):183-90. PubMed ID: 10361725
    [Abstract] [Full Text] [Related]

  • 5. Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513.
    Wong YH, Kumar A, Liew CW, Tharakaraman K, Srinivasaraghavan K, Sasisekharan R, Verma C, Lescar J.
    Sci Rep; 2018 May 31; 8(1):8449. PubMed ID: 29855525
    [Abstract] [Full Text] [Related]

  • 6. Characterization of two anti-dengue human monoclonal antibodies prepared from PBMCs of patients with dengue illness in Thailand.
    Li ZY, Yamashita A, Kawashita N, Sasaki T, Pan Y, Ono KI, Ikuta K, Li YG.
    Acta Virol; 2016 Jun 31; 60(2):166-73. PubMed ID: 27265466
    [Abstract] [Full Text] [Related]

  • 7. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.
    Falconar AK.
    Arch Virol; 1999 Jun 31; 144(12):2313-30. PubMed ID: 10664386
    [Abstract] [Full Text] [Related]

  • 8. Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein.
    Tang CT, Liao MY, Chiu CY, Shen WF, Chiu CY, Cheng PC, Chang GJ, Wu HC.
    PLoS One; 2015 Jun 31; 10(8):e0136328. PubMed ID: 26309127
    [Abstract] [Full Text] [Related]

  • 9. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT, Bolin RA, Kelly RG.
    Virology; 1998 Jul 05; 246(2):317-28. PubMed ID: 9657950
    [Abstract] [Full Text] [Related]

  • 10. Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope.
    Li J, Watterson D, Chang CW, Che XY, Li XQ, Ericsson DJ, Qiu LW, Cai JP, Chen J, Fry SR, Cheung STM, Cooper MA, Young PR, Kobe B.
    Structure; 2018 Jan 02; 26(1):51-59.e4. PubMed ID: 29249606
    [Abstract] [Full Text] [Related]

  • 11. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.
    Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, Roehrig JT, Gromowski GD, Barrett AD, Fremont DH, Diamond MS.
    J Virol; 2007 Dec 02; 81(23):12816-26. PubMed ID: 17881453
    [Abstract] [Full Text] [Related]

  • 12. An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2.
    Tang CT, Li PC, Liu IJ, Liao MY, Chiu CY, Chao DY, Wu HC.
    PLoS Negl Trop Dis; 2015 Dec 02; 9(7):e0003903. PubMed ID: 26135599
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Generation and characterization of a monoclonal antibody that cross-reacts with the envelope protein from the four dengue virus serotypes.
    León-Juárez M, García-Cordero J, Santos-Argumedo L, Romero-Ramírez H, García-Machorro J, Bustos-Arriaga J, Gutiérrez-Castañeda B, Sepúlveda NV, Mellado-Sánchez G, Cedillo-Barrón L.
    APMIS; 2013 Sep 02; 121(9):848-58. PubMed ID: 23331315
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus.
    Lisova O, Belkadi L, Bedouelle H.
    J Mol Recognit; 2014 Apr 02; 27(4):205-14. PubMed ID: 24591178
    [Abstract] [Full Text] [Related]

  • 19. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD, Barrett AD.
    Virology; 2007 Sep 30; 366(2):349-60. PubMed ID: 17719070
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.